Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
Standard
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma. / Waizenegger, J S; Ben-Batalla, I; Weinhold, N; Meissner, T; Wroblewski, M; Janning, M; Riecken, K; Binder, M; Atanackovic, D; Taipaleenmaeki, Hanna; Schewe, D; Sawall, S; Gensch, V; Cubas-Cordova, M; Seckinger, A; Fiedler, W; Hesse, E; Kröger, N; Fehse, B; Hose, D; Klein, B; Raab, M S; Pantel, K; Bokemeyer, C; Loges, S.
In: LEUKEMIA, Vol. 29, No. 3, 01.03.2015, p. 696-704.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
AU - Waizenegger, J S
AU - Ben-Batalla, I
AU - Weinhold, N
AU - Meissner, T
AU - Wroblewski, M
AU - Janning, M
AU - Riecken, K
AU - Binder, M
AU - Atanackovic, D
AU - Taipaleenmaeki, Hanna
AU - Schewe, D
AU - Sawall, S
AU - Gensch, V
AU - Cubas-Cordova, M
AU - Seckinger, A
AU - Fiedler, W
AU - Hesse, E
AU - Kröger, N
AU - Fehse, B
AU - Hose, D
AU - Klein, B
AU - Raab, M S
AU - Pantel, K
AU - Bokemeyer, C
AU - Loges, S
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Multiple myeloma is a mostly incurable malignancy characterized by the expansion of a malignant plasma cell (PC) clone in the human bone marrow (BM). Myeloma cells closely interact with the BM stroma, which secretes soluble factors that foster myeloma progression and therapy resistance. Growth arrest-specific gene 6 (Gas6) is produced by BM-derived stroma cells and can promote malignancy. However, the role of Gas6 and its receptors Axl, Tyro3 and Mer (TAM receptors) in myeloma is unknown. We therefore investigated their expression in myeloma cell lines and in the BM of myeloma patients and healthy donors. Gas6 showed increased expression in sorted BMPCs of myeloma patients compared with healthy controls. The fraction of Mer(+) BMPCs was increased in myeloma patients in comparison with healthy controls whereas Axl and Tyro3 were not expressed by BMPCs in the majority of patients. Downregulation of Gas6 and Mer inhibited the proliferation of different myeloma cell lines, whereas knocking down Axl or Tyro3 had no effect. Inhibition of the Gas6 receptor Mer or therapeutic targeting of Gas6 by warfarin reduced myeloma burden and improved survival in a systemic model of myeloma. Thus, the Gas6-Mer axis represents a novel candidate for therapeutic intervention in this incurable malignancy.
AB - Multiple myeloma is a mostly incurable malignancy characterized by the expansion of a malignant plasma cell (PC) clone in the human bone marrow (BM). Myeloma cells closely interact with the BM stroma, which secretes soluble factors that foster myeloma progression and therapy resistance. Growth arrest-specific gene 6 (Gas6) is produced by BM-derived stroma cells and can promote malignancy. However, the role of Gas6 and its receptors Axl, Tyro3 and Mer (TAM receptors) in myeloma is unknown. We therefore investigated their expression in myeloma cell lines and in the BM of myeloma patients and healthy donors. Gas6 showed increased expression in sorted BMPCs of myeloma patients compared with healthy controls. The fraction of Mer(+) BMPCs was increased in myeloma patients in comparison with healthy controls whereas Axl and Tyro3 were not expressed by BMPCs in the majority of patients. Downregulation of Gas6 and Mer inhibited the proliferation of different myeloma cell lines, whereas knocking down Axl or Tyro3 had no effect. Inhibition of the Gas6 receptor Mer or therapeutic targeting of Gas6 by warfarin reduced myeloma burden and improved survival in a systemic model of myeloma. Thus, the Gas6-Mer axis represents a novel candidate for therapeutic intervention in this incurable malignancy.
U2 - 10.1038/leu.2014.236
DO - 10.1038/leu.2014.236
M3 - SCORING: Journal article
C2 - 25102945
VL - 29
SP - 696
EP - 704
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 3
ER -
